SCHEMBL1507628

SCHEMBL1507628

CCOC(=O)NC(OC)(OC)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.53
KDM4E B2RXH2 2/20 0.49
HPGD P15428 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.43
KCNN4 O15554 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GLA P06280 1/20 0.43
POLB P06746 1/20 0.43
THRB P10828 1/20 0.43
ATM Q13315 1/20 0.43
ALDH1A1 P00352 4/20 0.42
RECQL P46063 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29138685 0.83 KCNN4 (0.52) GAAKMT2AKCNN4MAPTPOLB
SCHEMBL2278045 0.81 GAA (0.53) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL10444412 0.81 GAA (0.53) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL2969420 0.80 GAA (0.51) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL9034322 0.79 KDM4E (0.50) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL28397741 0.79 KDM4E (0.50) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL9828915 0.76 KDM4E (0.51) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL9828908 0.76 KDM4E (0.51) GAAKDM4EHPGDNPC1RAB9A
SCHEMBL3362413 0.76 KCNN4 (0.48) KMT2ALMNAKCNN4MAPTMAPK1
Diphenylmethane SCHEMBL18115121 0.74 KDM4E (0.46) GAAKDM4EHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12152279-B2 Photoactive compounds and methods for biomolecule detection and sequencing VIBRANT HOLDINGS, LLC (US) 2024-11-26 US claimed
US-20220162698-A1 PHOTOACTIVE COMPOUNDS AND METHODS FOR BIOMOLECULE DETECTION AND SEQUENCING VIBRANT HOLDINGS, LLC 2022-05-26 US claimed
US-11168365-B2 Photoactive compounds and methods for biomolecule detection and sequencing VIBRANT HOLDINGS, LLC (US) 2021-11-09 US claimed
WO-2018218250-A2 PHOTOACTIVE COMPOUNDS AND METHODS FOR BIOMOLECULE DETECTION AND SEQUENCING VIBRANT HOLDINGS, LLC (US) 2018-11-29 WO claimed
EP-2003501-B1 Inkless reimageable printing paper and method XEROX CORP (US) 2010-10-27 EP claimed
US-7582398-B2 Inkless reimageable printing paper and method XEROX CORPORATION (US) 2009-09-01 US claimed
US-7572569-B2 Inkless printing paper and method XEROX CORPORATION (US) 2009-08-11 US claimed
US-7553603-B2 Inkless printing paper and method XEROX CORPORATION (US) 2009-06-30 US claimed
US-20080311518-A1 INKLESS PRINTING PAPER AND METHOD XEROX CORPORATION (US) 2008-12-18 US claimed
US-20080311516-A1 INKLESS PRINTING PAPER AND METHOD XEROX CORPORATION (US) 2008-12-18 US claimed
US-20080311492-A1 INKLESS REIMAGEABLE PRINTING PAPER AND METHOD XEROX CORPORATION (US) 2008-12-18 US claimed
EP-2003503-A1 Inkless printing paper and method Xerox Corporation (US) 2008-12-17 EP claimed
EP-2003502-A1 Inkless printing paper and method Xerox Corporation (US) 2008-12-17 EP claimed
EP-2003501-A1 Inkless reimageable printing paper and method Xerox Corporation (US) 2008-12-17 EP claimed
US-20260125496-A1 MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES ALIGN TECHNOLOGY INC (US) 2026-05-07 US disclosed
EP-4704757-A1 SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS Align Technology, Inc. (US) 2026-03-11 EP disclosed
EP-4685195-A1 DEGRADABLE CROSSLINKING AGENT NAGASE CHEMTEX CORPORATION (JP) 2026-01-28 EP disclosed
EP-1795553-A1 PROCESS FOR PRODUCING FOAM Oji Paper Co., Ltd. (JP) 2007-06-13 EP disclosed
US-20060210785-A1 Foamed product in a sheet form and method for production thereof OJI PAPER CO., LTD. (JP) 2006-09-21 US disclosed
EP-1647570-A1 FOAMED PRODUCT IN A SHEET FORM AND METHOD FOR PRODUCTION THEREOF Oji Paper Co., Ltd. (JP) 2006-04-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125496-A1 MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES SMCHD1, SMC4, SMC3 GAA 3727/4885KDM4E 14/4885HPGD 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.